Atherosclerosis in HIV Patients: What Do We Know so Far?
For the past several decades, humanity has been dealing with HIV. This disease is one of the biggest global health problems. Fortunately, modern antiretroviral therapy allows patients to manage the disease, improving their quality of life and their life expectancy. In addition, the use of these drug...
Main Authors: | Anastasia V. Poznyak, Evgeny E. Bezsonov, Evgeny E. Borisov, Andrey V. Grechko, Andrey G. Kartuesov, Alexander N. Orekhov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/5/2504 |
Similar Items
-
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
by: Anastasia V. Poznyak, et al.
Published: (2022-08-01) -
Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
by: Anastasia V. Poznyak, et al.
Published: (2022-08-01) -
Vaccination against Atherosclerosis: Is It Real?
by: Anastasia V. Poznyak, et al.
Published: (2022-02-01) -
Immunity in Atherosclerosis: Focusing on T and B Cells
by: Anastasia V. Poznyak, et al.
Published: (2021-08-01) -
Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis
by: Diana Salnikova, et al.
Published: (2021-08-01)